Ecovyst Inc.
No enriched coverage for $ECVT in the last 7 days.
Freedom Capital Markets kept a Buy rating and $15.00 price target on Ecovyst, implying 42.3% upside from the Sep 15 close. The firm cites Ecovyst's strong market position in sulfuric acid and positive financial outlook due to recent acquisitions and unit ramp-ups.
Humble Patti A. purchased 24,875 shares of Ecovyst Inc. (ECVT) at $10.05 ($0.25M total) on 2026-09-10.
Ecovyst Inc. (ECVT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Ecovyst Announces Chief Financial Officer Transition WAYNE, PA, August 24, 2026 — Ecovyst Inc. (NYSE: ECVT) (“Ecovyst” or the “Company”), a leading provider of regenerated sulfuric acid, virgin sulfuric acid, and sulfur dioxide and related derivatives, today announce
Recent ECVT coverage spans earnings, insider activity and corporate actions.
In the last 30 days, ECVT insiders filed 1 SEC Form 4 transaction — 1 purchase ($250K) and no sales. The most active reporter was Humble Patti A. with 1 filing.
Freedom Capital Markets kept a Buy rating and $15.00 price target on Ecovyst, implying 42.3% upside from the Sep 15 close. The firm cites Ecovyst's strong market position in sulfuric acid and positive financial outlook due to recent acquisitions and unit ramp-ups.
Insider purchase may signal confidence but size is modest relative to float.
Executive transition may affect financial strategy and investor perception.
Guidance revision and acquisition-funded leverage shift the near-term risk-reward, with sulfur price pass-through and volume assumptions driving earnings sensitivity.
Guidance raise tied to Calabrian integration and sulfur pass-through materially changes 2026 revenue and EBITDA expectations, with leverage rising to 2.0x.
AlphAI scores every news story that mentions ECVT with an AI model for sentiment and relevance, and aggregates insider trades from Ecovyst Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Freedom Capital Markets kept a Buy rating and $15.00 price target on Ecovyst, implying 42.3% upside from the Sep 15 close. The firm cites Ecovyst's strong market position in sulfuric acid and positive financial outlook due to recent acquisitions and unit ramp-ups.
1 min readHumble Patti A. purchased 24,875 shares of Ecovyst Inc. (ECVT) at $10.05 ($0.25M total) on 2026-09-10.
1 min readEcovyst Inc. (ECVT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Ecovyst Announces Chief Financial Officer Transition WAYNE, PA, August 24, 2026 — Ecovyst Inc. (NYSE: ECVT) (“Ecovyst” or the “Company”), a leading provider of regenerated sulfuric acid, virgin sulfuric acid, and sulfur dioxide and related derivatives, today announce
1 min readEcovyst (ECVT) discussed its Q2 2026 results and strategy on an earnings call. The company closed the Calabrian sulfur dioxide business on June 30, and said Q2 sales rose to $250 million and adjusted EBITDA was $53 million. It reported $13 million adjusted free cash flow for the first half and net debt leverage of 2x after the acquisition. Guidance was revised for higher sulfur pass-through.
7 min readEcovyst (NYSE:ECVT) said integration of its Calabrian acquisition is progressing as planned, with no customer disruptions, and expects $3m to $4m in cost and revenue synergies that would lower the acquisition multiple. Q2 sales rose $74m, including $55m sulfur pass-through. It raised 2026 guidance to $1.02b-$1.06b sales and $195m-$207m adjusted EBITDA, citing Calabrian.
6 min readEcovyst (NYSE:ECVT) reported Q2 adjusted EPS of $0.21, above the $0.19 consensus, on revenue up 42% to $250 million versus $237.48 million expected. The company raised 2026 guidance: adjusted EBITDA to $195m-$207m and revenue to $1.02b-$1.06b. It also closed an INEOS sulfur dioxide derivatives acquisition in June 2026.
5 min readEcovyst Inc. (NYSE: ECVT) reported Q2 2026 sales of $250.0 million, up 42% year over year, and net income of $10.7 million. Adjusted EBITDA rose 27% to $53.1 million. The company completed the Calabrian sulfur dioxide acquisition on June 30, 2026 and raised full-year 2026 Adjusted EBITDA guidance to $195 million to $207 million.
4 min readEcovyst Inc. (ECVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ecovyst Reports Second Quarter 2026 Results and Raises 2026 Outlook WAYNE, PA, August 5, 2026 -- Ecovyst Inc. (NYSE: ECVT) (“Ecovyst” or the “Company”), a leading provider of regenerated sulfuric acid, virgin sulfuric acid, and sulfur dioxide and related derivatives,
6 min readEcovyst Inc. (ECVT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 d833981dex101.htm EX-10.1 EX-10.1 Exhibit 10.1 Execution Version FOURTH AMENDMENT AGREEMENT This FOURTH AMENDMENT AGREEMENT, dated as of June 30, 2026 (this “ Fourth Amendment ”), is entered into by and among Ecovyst Catalyst Technologies LLC, a Delaware limited liabili
4 min readLorance Sarah sold 8,450 shares of Ecovyst Inc. (ECVT) at $13.33 ($0.11M total) on 2026-06-02.
2 min read
